MYUNGMOON PHARM CO.,LTD Logo

MYUNGMOON PHARM CO.,LTD

Develops, manufactures, and commercializes specialized and general medicines.

017180 | KO

Overview

Corporate Details

ISIN(s):
KR7017180001
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단2길 26, 화성시

Description

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-06-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2022-06-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2022-06-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2022-06-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2022-06-03 00:00
조회공시요구(풍문또는보도)에대한답변(부인)
Korean 4.7 KB
2022-05-13 00:00
분기보고서 (2022.03)
Korean 1.1 MB
2022-05-12 00:00
주식등의대량보유상황보고서(일반)
Korean 75.2 KB
2022-04-12 00:00
주식등의대량보유상황보고서(일반)
Korean 75.2 KB
2022-03-31 00:00
[기재정정]사업보고서 (2021.12)
Korean 1.5 MB
2022-03-29 00:00
정기주주총회결과
Korean 26.4 KB
2022-03-22 00:00
[기재정정]주주총회소집결의
Korean 17.0 KB
2022-03-22 00:00
[기재정정]주주총회소집공고
Korean 1.8 MB
2022-03-22 00:00
[기재정정]주주총회소집공고
Korean 1.8 MB
2022-03-22 00:00
[기재정정]의결권대리행사권유참고서류
Korean 369.7 KB
2022-03-22 00:00
사업보고서 (2021.12)
Korean 494.7 KB

Automate Your Workflow. Get a real-time feed of all MYUNGMOON PHARM CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MYUNGMOON PHARM CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MYUNGMOON PHARM CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.